Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists-Reference-Cited by-同舟云学术

Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists

Published:2020-02-14 Issue:10 Volume:11 Page:1935-1941
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Tosh Dilip K.¹,Salmaso Veronica¹,Rao Harsha¹,Campbell Ryan¹,Bitant Amelia²,Gao Zhan-Guo¹,Auchampach John A.²,Jacobson Kenneth A.¹^ORCID

Affiliation:

1. Laboratory of Bioorganic Chemistry, Mouse Metabolism Core, and Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States

2. Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00637

Reference38 articles.

1. A3Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy